Themis Medicare Ltd
Themis Medicare Ltd (THEMISMED) last reported results for the quarter ended Jun 2026, with sales of ₹87 crore and net profit of ₹25 crore. The stock last traded at ₹114, a market capitalisation of ₹1,053 crore. Over the past 52 weeks the stock has ranged between ₹65 and ₹147. Figures are as of 6 Oct 2026 and are not real time.
Themis Medicare Ltd share price and key metrics
- Current price
- ₹114
- Market cap
- ₹1,053 cr
- Book value
- ₹43.3
- ROE
- 0.41%
- ROCE
- 2.74%
- Dividend yield
- 0.44%
- 52w high / low
- 147/65.0
Metrics as of 6 Oct 2026. Not real time.
Track Themis Medicare Ltd
Cruxal reads every Themis Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Themis Medicare Ltd growth and returns
- 10 Years
- 4%
- 5 Years
- 8%
- 3 Years
- -1%
- TTM
- -13%
- 10 Years
- -20%
- 5 Years
- -46%
- 3 Years
- -69%
- TTM
- -321%
- 10 Years
- 7%
- 5 Years
- 3%
- 3 Years
- -16%
- 1 Year
- -14%
- 10 Years
- 11%
- 5 Years
- 12%
- 3 Years
- 6%
- Last Year
- 0%
Themis Medicare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹87 cr, down 11.2% from ₹98 cr a year earlier. Net profit turned positive at ₹25 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 117 | 94 | 72 | 98 | 78 | 90 | 77 | 87 |
| Expenses | 100 | 88 | 79 | 108 | 81 | 80 | 73 | 139 |
| Operating profit | 17 | 6 | -8 | -10 | -3 | 10 | 4 | -52 |
| OPM % | 15% | 6% | -11% | -10% | -4.0% | 11% | 4.9% | -60% |
| Other income | 6 | 1 | 2 | 1 | 5 | 6 | 11 | 97 |
| Interest | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 18 | 2 | -11 | -14 | -3 | 10 | 9 | 39 |
| Tax % | 20% | 69% | -13% | 1% | 5% | 3% | 2% | 36% |
| Net profit | 14 | 1 | -10 | -14 | -4 | 10 | 9 | 25 |
| EPS (₹) | 1.55 | 0.06 | -1.05 | -1.54 | -0.39 | 1.10 | 0.97 | 2.67 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Themis Medicare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 217 | 210 | 184 | 202 | 231 | 395 | 354 | 382 | 406 | 342 | 332 |
| Operating profit | 33 | 25 | 2 | 36 | 49 | 96 | 67 | 52 | 49 | 0 | -42 |
| OPM % | 15% | 12% | 1.2% | 18% | 21% | 24% | 19% | 13% | 12% | 0.1% | -13% |
| Net profit | 16 | 11 | -11 | 25 | 36 | 73 | 57 | 44 | 30 | 1 | 40 |
| EPS (₹) | 1.77 | 1.23 | -1.17 | 2.70 | 3.88 | 7.92 | 6.18 | 4.73 | 3.24 | 0.12 | 4.35 |
TTM is the trailing twelve months to the most recent quarter.
Themis Medicare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 143 | 160 | 149 | 174 | 209 | 278 | 330 | 368 | 393 | 389 |
| Borrowings | 82 | 80 | 82 | 100 | 87 | 80 | 92 | 96 | 83 | 100 |
| Other liabilities | 54 | 56 | 74 | 67 | 65 | 61 | 82 | 93 | 102 | 99 |
| Total liabilities | 289 | 305 | 314 | 350 | 371 | 428 | 514 | 566 | 588 | 598 |
| Fixed assets | 124 | 126 | 123 | 116 | 133 | 144 | 162 | 168 | 172 | 167 |
| CWIP | 9 | 2 | 2 | 8 | 2 | 3 | 3 | 3 | 3 | 2 |
| Investments | 23 | 24 | 27 | 35 | 45 | 56 | 70 | 89 | 95 | 109 |
| Other assets | 133 | 153 | 162 | 191 | 191 | 225 | 279 | 307 | 318 | 320 |
| Total assets | 289 | 305 | 314 | 350 | 371 | 428 | 514 | 566 | 588 | 598 |
As reported by the company. Total assets equal total liabilities by construction.
Themis Medicare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2 | 8 | 11 | 0 | 57 | 34 | 16 | 22 | 35 | -3 |
| Cash from investing | -4 | -0 | -4 | -5 | -16 | -16 | -24 | -16 | -12 | -3 |
| Cash from financing | 5 | -9 | -10 | 7 | -26 | -18 | 0 | -9 | -26 | 4 |
| Net cash flow | -0 | -1 | -3 | 2 | 16 | 1 | -8 | -3 | -3 | -2 |
| Free cash flow | -7 | 5 | 5 | -5 | 39 | 15 | -13 | 4 | 21 | -8 |
| CFO / operating profit | -5% | 29% | 490% | 2% | 115% | 55% | 48% | 60% | 93% | 782% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Themis Medicare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 13% | 10% | -1% | 15% | 18% | 30% | 20% | 14% | 10% | 3% |
| Debtor days | 81 | 120 | 145 | 186 | 123 | 93 | 149 | 170 | 159 | 190 |
| Inventory days | 250 | 253 | 287 | 315 | 272 | 150 | 213 | 188 | 233 | 229 |
| Days payable | 163 | 156 | 187 | 171 | 143 | 79 | 123 | 126 | 142 | 143 |
| Cash conversion cycle | 168 | 216 | 244 | 330 | 251 | 164 | 239 | 232 | 250 | 275 |
| Working capital days | -16 | 19 | -1 | 37 | 51 | 72 | 110 | 114 | 121 | 138 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Themis Medicare Ltd shareholding pattern
Promoters held 67.10% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.01% and DIIs 0.01%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.15% | 67.15% | 67.15% | 67.15% | 67.15% | 67.10% | 67.10% | 67.10% |
| FIIs | 0.10% | 0.10% | 0.14% | 0.09% | 0.06% | 0.05% | 0.11% | 0.01% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 32.74% | 32.75% | 32.70% | 32.75% | 32.77% | 32.84% | 32.78% | 32.87% |
| No. of shareholders | 14,270 | 17,773 | 17,889 | 19,335 | 22,490 | 22,576 | 21,818 | 21,267 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Themis Medicare Ltd corporate filings
- Credit rating downgrade of Themis Medicare Limited reflects deteriorating financial health and liquidity concernsCompany Updatehigh impact
Cruxal's analysis: Themis Medicare Limited's credit ratings have been downgraded by CARE Ratings due to a…
Read the full analysis - Themis Medicare Limited Passes Shareholder Resolutions at 56th AGM with Over 99.99% Voting Support, Including Dividend Declaration and Articles of Association AmendmentAGM/EGMmedium impact
Cruxal's analysis: Themis Medicare Limited conducted its 56th AGM on 30th September 2026, where all…
Read the full analysis - Themis Medicare Limited's credit rating downgrade to CARE BB+; Stable from CARE BBB-; Negative signals increased credit risk and potential liquidity concerns, which could negatively impact investor sentiment and valuation multiples.Company Updatehigh impact
Cruxal's analysis: Themis Medicare Limited has received a credit rating downgrade from CARE BBB-; Negative…
Read the full analysis - Themis Medicare Ltd amends Memorandum & Articles of Association as per Regulation 30 of SEBI (LODR) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Themis Medicare Ltd has issued an intimation regarding amendments to its Memorandum and…
Read the full analysis - Themis Medicare Ltd amends Memorandum & Articles of Association as per Regulation 30 (LODR)Company Updatelow impact
Cruxal's analysis: Themis Medicare Ltd announced amendments to its Memorandum and Articles of Association on…
Read the full analysis - Themis Medicare Limited holds its 56th AGM with no immediate financial disclosures; recent financials show fluctuating profit margins and revenue, with a notable decline in net profit in Dec 2024 and subsequent losses projected through Mar 2025 and Jun 2025, before a modest recovery in Dec 2025 and Mar 2026. The company’s latest annual general meeting primarily covered procedural matters, with no new strategic or financial announcements. Given the absence of significant financial updates or strategic events, the announcement is unlikely to have a material short-term impact on investor sentiment or valuation multiples.AGM/EGMlow impact
Cruxal's analysis: Themis Medicare Limited conducted its 56th AGM on 30th September 2026, focusing on…
Read the full analysis - Themis Medicare Limited withdraws proposed preferential issue of 45.96 lakh convertible equity warrantsCompany Updatemedium impact
Cruxal's analysis: Themis Medicare Limited has officially withdrawn its previously proposed preferential…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please refer to our Intimation of closure of Trading window for the declaration of…
Read the full analysis - Themis Medicare Limited fixes September 23, 2026, as record date for final dividend for FY 2025-26Corp. Actionlow impact
Cruxal's analysis: Themis Medicare Limited has officially announced Wednesday, September 23, 2026, as the…
Read the full analysis - Themis Medicare Limited announces 56th Annual General Meeting, e-voting, and book closure detailsCompany Updatelow impact
Cruxal's analysis: Themis Medicare Limited has issued a formal intimation regarding its 56th Annual General…
Read the full analysis - Themis Medicare Ltd releases Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Themis Medicare has filed its Business Responsibility and Sustainability Report (BRSR)…
Read the full analysis - Themis Medicare Ltd releases Annual Report for F.Y. 2025-26Otherslow impact
Cruxal's analysis: Themis Medicare Ltd has filed its Annual Report for the financial year 2025-26 in…
Read the full analysis - Themis Medicare Limited Announces 56th AGM and Releases Annual Report for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Themis Medicare Limited has released its Annual Report for the financial year ended 31st…
Read the full analysis - Themis Medicare Ltd updates contact details for Company Secretary and RTACompany Updatelow impact
Cruxal's analysis: Themis Medicare Ltd has issued a routine regulatory filing under Regulation 30 of the…
Read the full analysis - Themis Medicare Limited Announces Unaudited Financial Results for the Quarter Ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Themis Medicare Limited has released its unaudited standalone and consolidated financial…
Read the full analysis - Themis Medicare Q1 FY27 Results: Profitability Boosted by One-off Gains Amidst Revenue ContractionCompany Updatemedium impact
Cruxal's analysis: Themis Medicare Limited reported Q1 FY27 consolidated revenue of 86.96 crore, a 10.9%…
Read the full analysis - Themis Medicare Ltd files update regarding Regulation 30(5) of SEBI LODRCompany Updatelow impact
Cruxal's analysis: Themis Medicare Ltd has submitted a routine disclosure under Regulation 30(5) of the SEBI…
Read the full analysis - Themis Medicare Reports Q1 FY27 Results Driven by Exceptional Gain from Sale of Investment in Gujarat Themis BiosynBoard Meetinghigh impact
Cruxal's analysis: Themis Medicare Limited reported standalone net profit of 28.74 crore for the quarter…
Read the full analysis - Themis Medicare Limited: Pledge of 30 lakh shares created by Vividhmargi Trust in favor of Debenture TrusteeInsider Trading / SASTmedium impact
Cruxal's analysis: Themis Medicare Limited has reported that the Vividhmargi Trust has pledged an additional…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.